Filing Details
- Accession Number:
- 0001104659-22-045488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-13 16:05:46
- Reporting Period:
- 2022-04-11
- Accepted Time:
- 2022-04-13 16:05:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006281 | Protalix Biotherapeutics Inc. | PLX | Biological Products, (No Disgnostic Substances) (2836) | 650643773 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1781450 | Dror Bashan | C/O Protalix Biotherapeutics, Inc. 2 Snunit Street Science Park, Pob 455 Carmiel L3 2161401 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-11 | 68,000 | $1.50 | 68,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,085,458 | Indirect | By Trust |
Footnotes
- The reporting person holds the shares in an account with his spouse as joint tenants.
- Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.
Billionaire Hedge Funds
